0,705  0,004  Huntington's disease treatment
0,657  0,005  Renal disease treatment
0,591  0,004  Phosphodiesterase inhibitor
0,590  0,016  Atherosclerosis treatment
0,518  0,010  Heart failure treatment
0,503  0,031  5 Hydroxytryptamine release inhibitor
0,463  0,015  Vascular (periferal) disease treatment
0,468  0,027  Multiple sclerosis treatment
0,471  0,037  Aldehyde oxidase inhibitor
0,433  0,005  Renal failure treatment
0,458  0,052  Antiparkinsonian
0,405  0,005  Psychosexual dysfunction treatment
0,439  0,055  Histamine release inhibitor
0,403  0,025  Urologic disorders treatment
0,423  0,052  GABA C receptor rho-3 antagonist
0,429  0,062  Calcium channel L-type activator
0,375  0,011  Urolithiasis treatment
0,409  0,049  Inflammatory Bowel disease treatment
0,327  0,004  Antifibrinolytic
0,377  0,069  Ulceration
0,358  0,056  Antihypertensive
0,341  0,042  Antihypoxic
0,311  0,015  Hemostatic
0,350  0,055  Antiischemic
0,324  0,042  Antiglaucomic
0,286  0,012  Pulmonary hypertension treatment
0,336  0,065  Antifungal
0,274  0,004  Phosphodiesterase II inhibitor
0,262  0,004  Phosphodiesterase 2A inhibitor
0,300  0,044  UGT1A6 substrate
0,326  0,074  ICAM1 expression inhibitor
0,286  0,038  MAP-kinase-activated kinase 5 inhibitor
0,304  0,059  UGT1A9 substrate
0,312  0,069  Nootropic
0,270  0,032  Male reproductive disfunction treatment
0,243  0,016  Gout treatment
0,244  0,016  Cystathionine beta-synthase inhibitor
0,339  0,134  Alzheimer's disease treatment
0,218  0,016  Xanthine oxidase inhibitor
0,288  0,087  Hepatic disorders treatment
0,204  0,005  Phosphodiesterase X inhibitor
0,204  0,005  Phosphodiesterase 10A inhibitor
0,294  0,095  Cholesterol antagonist
0,201  0,013  Uric acid excretion stimulant
0,216  0,029  Antidiarrheal
0,237  0,052  UGT1A1 substrate
0,210  0,031  M18 aspartyl aminopeptidase inhibitor
0,188  0,013  Creatine kinase inhibitor
0,242  0,068  Cyclic AMP phosphodiesterase inhibitor
0,202  0,029  Cell wall synthesis inhibitor
0,179  0,013  Phosphodiesterase I inhibitor
0,283  0,119  Cognition disorders treatment
0,203  0,039  Erectile dysfunction treatment
0,167  0,004  Guanylate cyclase stimulant
0,281  0,122  CYP2C9 substrate
0,206  0,053  Diabetic nephropathy treatment
0,193  0,041  Heat shock protein 90 antagonist
0,186  0,036  Antianemic
0,169  0,018  Antiviral (Influenza B)
0,230  0,081  Antiamyloidogenic
0,263  0,115  Sodium/bile acid cotransporter inhibitor
0,159  0,013  CC chemokine 6 receptor antagonist
0,166  0,028  GABA C receptor agonist
0,146  0,011  Phosphodiesterase 5A inhibitor
0,240  0,106  Insulysin inhibitor
0,215  0,088  Antihypotensive
0,138  0,013  Phosphodiesterase V inhibitor
0,197  0,074  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,175  0,053  Amylase inhibitor
0,145  0,024  Antifungal (Pneumocystis)
0,125  0,007  Dihydroorotate dehydrogenase inhibitor
0,202  0,086  Fibrosis treatment
0,129  0,013  Dysmenorrhea treatment
0,126  0,013  HIV-1 integrase inhibitor
0,232  0,121  FMO3 substrate
0,121  0,010  Phosphodiesterase 1B inhibitor
0,181  0,072  Antianginal
0,190  0,081  Antiviral (Influenza)
0,187  0,079  UDP-glucuronosyltransferase substrate
0,134  0,026  Alcohol dehydrogenase inhibitor
0,166  0,059  UGT2B15 substrate
0,175  0,071  UGT1A4 substrate
0,189  0,086  Insulin sensitizer
0,112  0,013  Purinergic P2X1 antagonist
0,125  0,027  Porphobilinogen synthase inhibitor
0,160  0,062  Raynaud's phenomenon treatment
0,105  0,009  Factor IXa inhibitor
0,174  0,078  Myocardial ischemia treatment
0,105  0,009  Heat shock protein 90 beta antagonist
0,218  0,125  Anxiolytic
0,227  0,136  AR expression inhibitor
0,252  0,161  CYP2C9 inhibitor
0,237  0,147  Vasodilator, coronary
0,282  0,192  Autoimmune disorders treatment
0,205  0,115  DNA synthesis inhibitor
0,240  0,151  Stroke treatment
0,209  0,121  Tyrosine 3 hydroxylase inhibitor
0,131  0,043  NAT2 substrate
0,158  0,074  Peroxidase inhibitor
0,155  0,072  Interferon gamma antagonist
0,086  0,005  Nicotinic acid receptor agonist
0,113  0,033  NADH dehydrogenase inhibitor
0,097  0,019  Alcohol oxidase inhibitor
0,091  0,012  Plasminogen activator inhibitor antagonist
0,164  0,088  Succinate dehydrogenase inhibitor
0,105  0,030  Myeloperoxidase inhibitor
0,141  0,068  Ca2+-transporting ATPase inhibitor
0,160  0,088  Phospholipase C inhibitor
0,165  0,093  Wound healing agent
0,130  0,058  Antitussive
0,092  0,021  MAP kinase kinase 7 inhibitor
0,147  0,077  GABA C receptor rho-2 antagonist
0,088  0,020  Xanthine dehydrogenase inhibitor
0,117  0,049  DOPA decarboxylase inhibitor
0,098  0,031  Purinergic P2X2 antagonist
0,180  0,114  Antiviral (HIV)
0,145  0,081  Diuretic
0,081  0,019  Phosphodiesterase 1C inhibitor
0,171  0,108  Pneumotoxic
0,088  0,026  Female sexual dysfunction treatment
0,191  0,130  Antineoplastic (ovarian cancer)
0,182  0,125  Antidiabetic symptomatic
0,073  0,017  Myc inhibitor
0,156  0,099  Toxic, respiratory center
0,107  0,053  GABA C receptor rho-1 antagonist
0,108  0,054  Antifungal (Aspergillus)
0,088  0,035  SULT1A2 substrate
0,059  0,007  Angiotensin AT1 receptor antagonist
0,104  0,052  Phosphodiesterase 7B inhibitor
0,087  0,038  Glutamate decarboxylase inhibitor
0,075  0,027  MDM2 inhibitor
0,134  0,088  Antidiabetic (type 1)
0,052  0,006  Angiotensin II receptor antagonist
0,129  0,084  Protein kinase stimulant
0,108  0,063  Ferrochelatase inhibitor
0,104  0,061  Adenylate kinase inhibitor
0,096  0,052  Triose-phosphate isomerase inhibitor
0,215  0,174  FMO1 substrate
0,082  0,041  Histidine decarboxylase inhibitor
0,095  0,055  Antithrombocytopenic
0,277  0,237  Antiinflammatory
0,097  0,058  Potassium channel (Ca-activated) activator
0,180  0,142  Superoxide dismutase inhibitor
0,098  0,060  Electrolyte absorption antagonist
0,116  0,079  Glutamate receptor antagonist
0,097  0,060  Lanosterol 14 alpha demethylase inhibitor
0,137  0,101  Heat shock protein 90 alpha antagonist
0,279  0,243  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,132  0,097  Thrombolytic
0,081  0,047  Viral attachment inhibitor
0,191  0,157  Antipsoriatic
0,052  0,018  Phosphodiesterase 6C inhibitor
0,115  0,083  Alpha-N-acetylglucosaminidase inhibitor
0,146  0,115  Catenin beta inhibitor
0,123  0,091  Antimutagenic
0,064  0,032  Phosphodiesterase 1A inhibitor
0,051  0,020  Nicotinic acid receptor 1 agonist
0,189  0,158  UGT2B4 substrate
0,224  0,194  Antipruritic, allergic
0,103  0,073  Protein kinase (CK2) alpha inhibitor
0,046  0,016  Nicotinic acid receptor 2 agonist
0,065  0,036  Biliverdin reductase inhibitor
0,192  0,165  Metabolic disease treatment
0,063  0,037  Plasminogen activator inhibitor
0,050  0,024  Dihydroorotase inhibitor
0,047  0,021  Urate transporter 1 inhibitor
0,076  0,051  GABA aminotransferase inhibitor
0,034  0,010  Protocollagen prolyl hydroxylase inhibitor
0,028  0,005  Nicotinic acid receptor 1 antagonist
0,028  0,004  Egl nine homolog 2 inhibitor
0,058  0,035  Leukotriene C antagonist
0,084  0,061  NMDA receptor antagonist
0,099  0,078  GABA receptor agonist
0,077  0,055  Macrophage migration inhibitory factor inhibitor
0,149  0,128  Antirickettsial
0,091  0,072  Protein kinase (CK2) inhibitor
0,122  0,103  SULT1A3 substrate
0,087  0,070  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,079  0,063  Phosphodiesterase IV inhibitor
0,063  0,047  Neuraminidase (influenza) inhibitor
0,024  0,010  Angiotensin AT1A receptor antagonist
0,070  0,056  Glutamate dehydrogenase inhibitor
0,089  0,076  Carbonic anhydrase III inhibitor
0,054  0,042  Adenine nucleotide translocase inhibitor
0,068  0,056  Lipase inhibitor
0,130  0,119  Heat shock protein 70 antagonist
0,172  0,161  Proliferative diseases treatment
0,138  0,127  Pyruvate kinase inhibitor
0,060  0,050  Leukotriene antagonist
0,101  0,091  Menstruation disorders treatment
0,047  0,038  Topoisomerase II beta inhibitor
0,144  0,134  Abortion inducer
0,049  0,040  Antiviral (Hepatitis D)
0,049  0,040  Aconitate hydratase inhibitor
0,033  0,025  Factor XI inhibitor
0,112  0,103  Liver cirrhosis treatment
0,078  0,070  Antiviral (Dengue virus)
0,052  0,043  Thromboxane synthase inhibitor
0,040  0,032  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,036  0,028  NMDA receptor subunit 3A antagonist
0,046  0,039  Dopamine beta hydroxylase inhibitor
0,120  0,113  Protein-tyrosine phosphatase inhibitor
0,119  0,112  Genotoxic
0,164  0,159  Cardiotonic
0,091  0,085  UGT2B1 substrate
0,019  0,013  Factor IX inhibitor
0,061  0,055  Cyclin B3 inhibitor
0,098  0,092  TRPA1 agonist
0,014  0,009  Angiotensin AT1B receptor antagonist
0,038  0,033  CF transmembrane conductance regulator antagonist
0,150  0,146  Antihypercholesterolemic
0,061  0,057  Phenylalanine 4-hydroxylase inhibitor
0,014  0,010  Egl nine homolog 1 inhibitor
0,086  0,082  Alpha 2d adrenoreceptor antagonist
0,037  0,034  Factor XIa inhibitor
0,059  0,057  Phosphofructokinase-1 inhibitor
0,084  0,082  UDP-glucose 4-epimerase inhibitor
0,016  0,014  Vesicular glutamate transport inhibitor
0,031  0,029  RNA-directed RNA polymerase inhibitor
0,011  0,010  Egl nine homolog 3 inhibitor
0,116  0,115  Urinary incontinence treatment
0,027  0,027  Phosphodiesterase 6B inhibitor
0,036  0,036  Leukotriene C4 antagonist

